Skip to Main Navigation
Skip to Page Content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Share This:
https://ntp.niehs.nih.gov/go/32649

Target Organs and Levels of Evidence for TR-548

Toxicology and Carcinogenesis Studies of Ethinyl Estradiol (CASRN 57-63-6) in Sprague-Dawley Rats (Feed Studies)

Chemical (Study Title)
CASRN
Peer Review Date Primary Uses Route/Exposure Levels Study Laboratory
Endocrine disruptor (Ethinyl estradiol)
57-63-6
05/16/2007 Nonsteroidal semi-synthetic estrogen used in the treatment of breast & prostate cancer. Associated with tobacco: reported either as a natural component of tobacco, pyrolysis product (in tobacco smoke), or additive for one or more types of tobacco products. Dosed-Feed
0, 2, 10, or 50 ppb
National Center for Toxicological Research

Levels of Evidence

F1C Male Rats: No Evidence
Type Organ/Tissue (Lesion)
Non-Neoplastic Lesions
  • Mammary Gland: alveolar hyperplasia (1/44, 4/45, 6/47, 18/44); ductal hyperplasia (0/44, 0/45, 2/47, 3/44)
  • Liver: basophilic focus (1/49, 3/49, 3/50, 17/49); eosinophilic focus (3/49, 5/49, 8/50, 15/49)

F1C Female Rats: No Evidence
Type Organ/Tissue (Lesion)
Non-Neoplastic Lesions
  • Uterus: endometrial hyperplasia (17/51, 18/50, 22/49, 25/50); squamous metaplasia (2/51, 6/50, 8/49, 13/50); atypical focal hyperplasia (6/51, 14/50, 16/49, 20/50)
  • Liver: eosinophilic focus (1/51, 1/50, 1/49, 5/50)

Levels of Evidence

F1T140 Male Rats: No Evidence
Type Organ/Tissue (Lesion)
Non-Neoplastic Lesions
  • Liver: basophilic focus (1/49, 3/50, 11/48, 6/49); eosinophilic focus (3/49, 11/50, 5/48, 10/49)
  • Mammary gland: alveolar hyperplasia (1/44, 2/45, 6/47, 14/48); ductal hyperplasia (0/44, 0/45, 1/47, 3/48)

F1T140 Female Rats: Equivocal Evidence
Type Organ/Tissue (Lesion)
May Have Been Related
  • Uterus: stromal polyp (2/51, 5/50, 6/50, 7/50)
Non-Neoplastic Lesions
  • Liver: basophilic focus (1/51, 1/50, 1/50, 6/50)
  • Clitoral Gland: hyperplasia (2/50, 1/50, 2/49, 8/49)

Levels of Evidence

F3T21 Male Rats: Equivocal Evidence
Type Organ/Tissue (Lesion)
May Have Been Related
  • Mammary Gland: adenoma or adenocarcinoma (0/42, 0/42, 0/40, 3/45)
  • Preputial Gland: epithelial neoplasms (2/49, 4/49, 4/50, 8/49)
Non-Neoplastic Lesions
  • Mammary Gland: alveolar hyperplasia (2/42, 6/42, 4/40, 9/45)

F3T21 Female Rats: Equivocal Evidence
Type Organ/Tissue (Lesion)
May Have Been Related
  • Uterus: stromal polyp (1/52,7/50, 2/50, 5/50)
Non-Neoplastic Lesions
  • Clitoral Gland: hyperplasia (0/50, 1/50, 2/49, 3/48)
  • Uterus: squamous metaplasia (1/52, 4/50, 3/50, 11/50); atypical focal hyperplasia (6/52, 16/50, 15/50, 21/50)